Shopping Cart 0
Cart Subtotal
AED 0

Global Drugs for Malaria Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 12772

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 19157

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 25543
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.

Anti-malarial Drugs are available only with a physician's prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.

Scope of the Report:

This report focuses on the Drugs for Malaria in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The classification of drugs for malaria includes aryl aminoalcohol compounds, antifolate compounds and artemisinin compounds. The proportion of aryl aminoalcohol compounds drugs for malaria in 2016 is about 16.8%, the proportion of antifolate compounds in 2016 is about 55.4% and the proportion of artemisinin compounds in 2016 is about 27.8%.

Drugs for malaria are application in Preventioning malaria, curing malaria and other areas. The most of drugs for malaria is used in Preventioning malaria; the market share in 2016 is about 56.1%. And 35.1% of drugs for malaria are used in curing malaria.

Market competition is intense. The major manufacturers are Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aventis and Ajanta Pharma in the United States.

The worldwide market for Drugs for Malaria is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million USD in 2023, from xx million USD in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Cipla

Guilin Pharmaceutical

IPCA Laboratories

GlaxoSmithKline

Mylan Labs

Roche

Novartis

Sanofi Aventis

Ajanta Pharma

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Aryl Aminoalcohol Compounds

Antifolate Compounds

Artemisinin Compounds

Market Segment by Applications, can be divided into

Prevention

Treatment

Other

There are 15 Chapters to deeply display the global Drugs for Malaria market.

Chapter 1, to describe Drugs for Malaria Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Drugs for Malaria, with sales, revenue, and price of Drugs for Malaria, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Drugs for Malaria, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Drugs for Malaria market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Drugs for Malaria sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

READ MORE

Table Of Content

Scope

Table of Contents

1 Market Overview

1.1 Drugs for Malaria Introduction

1.2 Market Analysis by Type

1.2.1 Aryl Aminoalcohol Compounds

1.2.2 Antifolate Compounds

1.2.3 Artemisinin Compounds

1.3 Market Analysis by Applications

1.3.1 Prevention

1.3.2 Treatment

1.3.3 Other

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Cipla

2.1.1 Business Overview

2.1.2 Drugs for Malaria Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Cipla Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Guilin Pharmaceutical

2.2.1 Business Overview

2.2.2 Drugs for Malaria Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Guilin Pharmaceutical Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 IPCA Laboratories

2.3.1 Business Overview

2.3.2 Drugs for Malaria Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 IPCA Laboratories Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 GlaxoSmithKline

2.4.1 Business Overview

2.4.2 Drugs for Malaria Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 GlaxoSmithKline Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Mylan Labs

2.5.1 Business Overview

2.5.2 Drugs for Malaria Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Mylan Labs Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Roche

2.6.1 Business Overview

2.6.2 Drugs for Malaria Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Roche Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Novartis

2.7.1 Business Overview

2.7.2 Drugs for Malaria Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Novartis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Sanofi Aventis

2.8.1 Business Overview

2.8.2 Drugs for Malaria Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Sanofi Aventis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Ajanta Pharma

2.9.1 Business Overview

2.9.2 Drugs for Malaria Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Ajanta Pharma Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Drugs for Malaria Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Drugs for Malaria Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Drugs for Malaria Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Drugs for Malaria Manufacturer Market Share in 2017

3.3.2 Top 6 Drugs for Malaria Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Drugs for Malaria Market Analysis by Regions

4.1 Global Drugs for Malaria Sales, Revenue and Market Share by Regions

4.1.1 Global Drugs for Malaria Sales and Market Share by Regions (2013-2018)

4.1.2 Global Drugs for Malaria Revenue and Market Share by Regions (2013-2018)

4.2 North America Drugs for Malaria Sales and Growth Rate (2013-2018)

4.3 Europe Drugs for Malaria Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Drugs for Malaria Sales and Growth Rate (2013-2018)

4.5 South America Drugs for Malaria Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Drugs for Malaria Sales and Growth Rate (2013-2018)

5 North America Drugs for Malaria by Countries

5.1 North America Drugs for Malaria Sales, Revenue and Market Share by Countries

5.1.1 North America Drugs for Malaria Sales and Market Share by Countries (2013-2018)

5.1.2 North America Drugs for Malaria Revenue and Market Share by Countries (2013-2018)

5.2 United States Drugs for Malaria Sales and Growth Rate (2013-2018)

5.3 Canada Drugs for Malaria Sales and Growth Rate (2013-2018)

5.4 Mexico Drugs for Malaria Sales and Growth Rate (2013-2018)

6 Europe Drugs for Malaria by Countries

6.1 Europe Drugs for Malaria Sales, Revenue and Market Share by Countries

6.1.1 Europe Drugs for Malaria Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Drugs for Malaria Revenue and Market Share by Countries (2013-2018)

6.2 Germany Drugs for Malaria Sales and Growth Rate (2013-2018)

6.3 UK Drugs for Malaria Sales and Growth Rate (2013-2018)

6.4 France Drugs for Malaria Sales and Growth Rate (2013-2018)

6.5 Russia Drugs for Malaria Sales and Growth Rate (2013-2018)

6.6 Italy Drugs for Malaria Sales and Growth Rate (2013-2018)

7 Asia-Pacific Drugs for Malaria by Countries

7.1 Asia-Pacific Drugs for Malaria Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Drugs for Malaria Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Drugs for Malaria Revenue and Market Share by Countries (2013-2018)

7.2 China Drugs for Malaria Sales and Growth Rate (2013-2018)

7.3 Japan Drugs for Malaria Sales and Growth Rate (2013-2018)

7.4 Korea Drugs for Malaria Sales and Growth Rate (2013-2018)

7.5 India Drugs for Malaria Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Drugs for Malaria Sales and Growth Rate (2013-2018)

8 South America Drugs for Malaria by Countries

8.1 South America Drugs for Malaria Sales, Revenue and Market Share by Countries

8.1.1 South America Drugs for Malaria Sales and Market Share by Countries (2013-2018)

8.1.2 South America Drugs for Malaria Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Drugs for Malaria Sales and Growth Rate (2013-2018)

8.3 Argentina Drugs for Malaria Sales and Growth Rate (2013-2018)

8.4 Colombia Drugs for Malaria Sales and Growth Rate (2013-2018)

9 Middle East and Africa Drugs for Malaria by Countries

9.1 Middle East and Africa Drugs for Malaria Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Drugs for Malaria Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Drugs for Malaria Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Drugs for Malaria Sales and Growth Rate (2013-2018)

9.3 UAE Drugs for Malaria Sales and Growth Rate (2013-2018)

9.4 Egypt Drugs for Malaria Sales and Growth Rate (2013-2018)

9.5 Nigeria Drugs for Malaria Sales and Growth Rate (2013-2018)

9.6 South Africa Drugs for Malaria Sales and Growth Rate (2013-2018)

10 Global Drugs for Malaria Market Segment by Type

10.1 Global Drugs for Malaria Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Drugs for Malaria Sales and Market Share by Type (2013-2018)

10.1.2 Global Drugs for Malaria Revenue and Market Share by Type (2013-2018)

10.2 Aryl Aminoalcohol Compounds Sales Growth and Price

10.2.1 Global Aryl Aminoalcohol Compounds Sales Growth (2013-2018)

10.2.2 Global Aryl Aminoalcohol Compounds Price (2013-2018)

10.3 Antifolate Compounds Sales Growth and Price

10.3.1 Global Antifolate Compounds Sales Growth (2013-2018)

10.3.2 Global Antifolate Compounds Price (2013-2018)

10.4 Artemisinin Compounds Sales Growth and Price

10.4.1 Global Artemisinin Compounds Sales Growth (2013-2018)

10.4.2 Global Artemisinin Compounds Price (2013-2018)

11 Global Drugs for Malaria Market Segment by Application

11.1 Global Drugs for Malaria Sales Market Share by Application (2013-2018)

11.2 Prevention Sales Growth (2013-2018)

11.3 Treatment Sales Growth (2013-2018)

11.4 Other Sales Growth (2013-2018)

12 Drugs for Malaria Market Forecast (2018-2023)

12.1 Global Drugs for Malaria Sales, Revenue and Growth Rate (2018-2023)

12.2 Drugs for Malaria Market Forecast by Regions (2018-2023)

12.2.1 North America Drugs for Malaria Market Forecast (2018-2023)

12.2.2 Europe Drugs for Malaria Market Forecast (2018-2023)

12.2.3 Asia-Pacific Drugs for Malaria Market Forecast (2018-2023)

12.2.4 South America Drugs for Malaria Market Forecast (2018-2023)

12.2.5 Middle East and Africa Drugs for Malaria Market Forecast (2018-2023)

12.3 Drugs for Malaria Market Forecast by Type (2018-2023)

12.3.1 Global Drugs for Malaria Sales Forecast by Type (2018-2023)

12.3.2 Global Drugs for Malaria Market Share Forecast by Type (2018-2023)

12.4 Drugs for Malaria Market Forecast by Application (2018-2023)

12.4.1 Global Drugs for Malaria Sales Forecast by Application (2018-2023)

12.4.2 Global Drugs for Malaria Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source


List Of Table

List of Tables and Figures

Figure Drugs for Malaria Picture

Table Product Specifications of Drugs for Malaria

Figure Global Sales Market Share of Drugs for Malaria by Types in 2017

Table Drugs for Malaria Types for Major Manufacturers

Figure Aryl Aminoalcohol Compounds Picture

Figure Antifolate Compounds Picture

Figure Artemisinin Compounds Picture

Figure Drugs for Malaria Sales Market Share by Applications in 2017

Figure Prevention Picture

Figure Treatment Picture

Figure Other Picture

Figure United States Drugs for Malaria Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Drugs for Malaria Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Drugs for Malaria Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Drugs for Malaria Revenue (Value) and Growth Rate (2013-2023)

Figure France Drugs for Malaria Revenue (Value) and Growth Rate (2013-2023)

Figure UK Drugs for Malaria Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Drugs for Malaria Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Drugs for Malaria Revenue (Value) and Growth Rate (2013-2023)

Figure China Drugs for Malaria Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Drugs for Malaria Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Drugs for Malaria Revenue (Value) and Growth Rate (2013-2023)

Figure India Drugs for Malaria Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Drugs for Malaria Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Drugs for Malaria Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Drugs for Malaria Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Drugs for Malaria Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Drugs for Malaria Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Drugs for Malaria Revenue (Value) and Growth Rate (2013-2023)

Table Cipla Basic Information, Manufacturing Base and Competitors

Table Cipla Drugs for Malaria Type and Applications

Table Cipla Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Guilin Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table Guilin Pharmaceutical Drugs for Malaria Type and Applications

Table Guilin Pharmaceutical Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table IPCA Laboratories Basic Information, Manufacturing Base and Competitors

Table IPCA Laboratories Drugs for Malaria Type and Applications

Table IPCA Laboratories Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors

Table GlaxoSmithKline Drugs for Malaria Type and Applications

Table GlaxoSmithKline Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Mylan Labs Basic Information, Manufacturing Base and Competitors

Table Mylan Labs Drugs for Malaria Type and Applications

Table Mylan Labs Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Roche Basic Information, Manufacturing Base and Competitors

Table Roche Drugs for Malaria Type and Applications

Table Roche Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Novartis Basic Information, Manufacturing Base and Competitors

Table Novartis Drugs for Malaria Type and Applications

Table Novartis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Sanofi Aventis Basic Information, Manufacturing Base and Competitors

Table Sanofi Aventis Drugs for Malaria Type and Applications

Table Sanofi Aventis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Ajanta Pharma Basic Information, Manufacturing Base and Competitors

Table Ajanta Pharma Drugs for Malaria Type and Applications

Table Ajanta Pharma Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Drugs for Malaria Sales by Manufacturer (2016-2017)

Figure Global Drugs for Malaria Sales Market Share by Manufacturer in 2016

Figure Global Drugs for Malaria Sales Market Share by Manufacturer in 2017

Table Global Drugs for Malaria Revenue by Manufacturer (2016-2017)

Figure Global Drugs for Malaria Revenue Market Share by Manufacturer in 2016

Figure Global Drugs for Malaria Revenue Market Share by Manufacturer in 2017

Figure Top 3 Drugs for Malaria Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Drugs for Malaria Manufacturer (Revenue) Market Share in 2017

Figure Global Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure Global Drugs for Malaria Revenue and Growth Rate (2013-2018)

Table Global Drugs for Malaria Sales by Regions (2013-2018)

Table Global Drugs for Malaria Sales Market Share by Regions (2013-2018)

Table Global Drugs for Malaria Revenue by Regions (2013-2018)

Figure Global Drugs for Malaria Revenue Market Share by Regions in 2013

Figure Global Drugs for Malaria Revenue Market Share by Regions in 2017

Figure North America Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure Europe Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure South America Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure North America Drugs for Malaria Revenue and Growth Rate (2013-2018)

Table North America Drugs for Malaria Sales by Countries (2013-2018)

Table North America Drugs for Malaria Sales Market Share by Countries (2013-2018)

Figure North America Drugs for Malaria Sales Market Share by Countries in 2013

Figure North America Drugs for Malaria Sales Market Share by Countries in 2017

Table North America Drugs for Malaria Revenue by Countries (2013-2018)

Table North America Drugs for Malaria Revenue Market Share by Countries (2013-2018)

Figure North America Drugs for Malaria Revenue Market Share by Countries in 2013

Figure North America Drugs for Malaria Revenue Market Share by Countries in 2017

Figure United States Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure Canada Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure Mexico Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure Europe Drugs for Malaria Revenue and Growth Rate (2013-2018)

Table Europe Drugs for Malaria Sales by Countries (2013-2018)

Table Europe Drugs for Malaria Sales Market Share by Countries (2013-2018)

Table Europe Drugs for Malaria Revenue by Countries (2013-2018)

Figure Europe Drugs for Malaria Revenue Market Share by Countries in 2016

Figure Europe Drugs for Malaria Revenue Market Share by Countries in 2017

Figure Germany Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure UK Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure France Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure Russia Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure Italy Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Drugs for Malaria Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Drugs for Malaria Sales by Countries (2013-2018)

Table Asia-Pacific Drugs for Malaria Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Drugs for Malaria Sales Market Share by Countries 2017

Table Asia-Pacific Drugs for Malaria Revenue by Countries (2013-2018)

Figure Asia-Pacific Drugs for Malaria Revenue Market Share by Countries 2017

Figure China Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure Japan Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure Korea Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure India Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure Southeast Asia Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure South America Drugs for Malaria Revenue and Growth Rate (2013-2018)

Table South America Drugs for Malaria Sales by Countries (2013-2018)

Table South America Drugs for Malaria Sales Market Share by Countries (2013-2018)

Figure South America Drugs for Malaria Sales Market Share by Countries in 2017

Table South America Drugs for Malaria Revenue by Countries (2013-2018)

Table South America Drugs for Malaria Revenue Market Share by Countries (2013-2018)

Figure South America Drugs for Malaria Revenue Market Share by Countries in 2017

Figure Brazil Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure Argentina Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure Colombia Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Drugs for Malaria Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Drugs for Malaria Sales by Countries (2013-2018)

Table Middle East and Africa Drugs for Malaria Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Drugs for Malaria Sales Market Share by Countries in 2017

Table Middle East and Africa Drugs for Malaria Revenue by Countries (2013-2018)

Table Middle East and Africa Drugs for Malaria Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Drugs for Malaria Revenue Market Share by Countries in 2013

Figure Middle East and Africa Drugs for Malaria Revenue Market Share by Countries in 2017

Figure Saudi Arabia Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure UAE Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure Egypt Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure Nigeria Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure South Africa Drugs for Malaria Sales and Growth Rate (2013-2018)

Table Global Drugs for Malaria Sales by Type (2013-2018)

Table Global Drugs for Malaria Sales Share by Type (2013-2018)

Table Global Drugs for Malaria Revenue by Type (2013-2018)

Table Global Drugs for Malaria Revenue Share by Type (2013-2018)

Figure Global Aryl Aminoalcohol Compounds Sales Growth (2013-2018)

Figure Global Aryl Aminoalcohol Compounds Price (2013-2018)

Figure Global Antifolate Compounds Sales Growth (2013-2018)

Figure Global Antifolate Compounds Price (2013-2018)

Figure Global Artemisinin Compounds Sales Growth (2013-2018)

Figure Global Artemisinin Compounds Price (2013-2018)

Table Global Drugs for Malaria Sales by Application (2013-2018)

Table Global Drugs for Malaria Sales Share by Application (2013-2018)

Figure Global Treatment Sales Growth (2013-2018)

Figure Global Other Sales Growth (2013-2018)

Figure Global Drugs for Malaria Sales, Revenue and Growth Rate (2018-2023)

Table Global Drugs for Malaria Sales Forecast by Regions (2018-2023)

Table Global Drugs for Malaria Market Share Forecast by Regions (2018-2023)

Figure North America Sales Drugs for Malaria Market Forecast (2018-2023)

Figure Europe Sales Drugs for Malaria Market Forecast (2018-2023)

Figure Asia-Pacific Sales Drugs for Malaria Market Forecast (2018-2023)

Figure South America Sales Drugs for Malaria Market Forecast (2018-2023)

Figure Middle East and Africa Sales Drugs for Malaria Market Forecast (2018-2023)

Table Global Drugs for Malaria Sales Forecast by Type (2018-2023)

Table Global Drugs for Malaria Market Share Forecast by Type (2018-2023)

Table Global Drugs for Malaria Sales Forecast by Application (2018-2023)

Table Global Drugs for Malaria Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List

Licence Rights

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Cipla

Guilin Pharmaceutical

IPCA Laboratories

GlaxoSmithKline

Mylan Labs

Roche

Novartis

Sanofi Aventis

Ajanta Pharma

Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.

Anti-malarial Drugs are available only with a physician's prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.

Scope of the Report:

This report focuses on the Drugs for Malaria in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The classification of drugs for malaria includes aryl aminoalcohol compounds, antifolate compounds and artemisinin compounds. The proportion of aryl aminoalcohol compounds drugs for malaria in 2016 is about 16.8%, the proportion of antifolate compounds in 2016 is about 55.4% and the proportion of artemisinin compounds in 2016 is about 27.8%.

Drugs for malaria are application in Preventioning malaria, curing malaria and other areas. The most of drugs for malaria is used in Preventioning malaria; the market share in 2016 is about 56.1%. And 35.1% of drugs for malaria are used in curing malaria.

Market competition is intense. The major manufacturers are Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aventis and Ajanta Pharma in the United States.

The worldwide market for Drugs for Malaria is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million USD in 2023, from xx million USD in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Cipla

Guilin Pharmaceutical

IPCA Laboratories

GlaxoSmithKline

Mylan Labs

Roche

Novartis

Sanofi Aventis

Ajanta Pharma

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Aryl Aminoalcohol Compounds

Antifolate Compounds

Artemisinin Compounds

Market Segment by Applications, can be divided into

Prevention

Treatment

Other

There are 15 Chapters to deeply display the global Drugs for Malaria market.

Chapter 1, to describe Drugs for Malaria Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Drugs for Malaria, with sales, revenue, and price of Drugs for Malaria, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Drugs for Malaria, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Drugs for Malaria market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Drugs for Malaria sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

READ MORE

Scope

Table of Contents

1 Market Overview

1.1 Drugs for Malaria Introduction

1.2 Market Analysis by Type

1.2.1 Aryl Aminoalcohol Compounds

1.2.2 Antifolate Compounds

1.2.3 Artemisinin Compounds

1.3 Market Analysis by Applications

1.3.1 Prevention

1.3.2 Treatment

1.3.3 Other

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Cipla

2.1.1 Business Overview

2.1.2 Drugs for Malaria Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Cipla Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Guilin Pharmaceutical

2.2.1 Business Overview

2.2.2 Drugs for Malaria Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Guilin Pharmaceutical Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 IPCA Laboratories

2.3.1 Business Overview

2.3.2 Drugs for Malaria Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 IPCA Laboratories Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 GlaxoSmithKline

2.4.1 Business Overview

2.4.2 Drugs for Malaria Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 GlaxoSmithKline Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Mylan Labs

2.5.1 Business Overview

2.5.2 Drugs for Malaria Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Mylan Labs Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Roche

2.6.1 Business Overview

2.6.2 Drugs for Malaria Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Roche Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Novartis

2.7.1 Business Overview

2.7.2 Drugs for Malaria Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Novartis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Sanofi Aventis

2.8.1 Business Overview

2.8.2 Drugs for Malaria Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Sanofi Aventis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Ajanta Pharma

2.9.1 Business Overview

2.9.2 Drugs for Malaria Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Ajanta Pharma Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Drugs for Malaria Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Drugs for Malaria Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Drugs for Malaria Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Drugs for Malaria Manufacturer Market Share in 2017

3.3.2 Top 6 Drugs for Malaria Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Drugs for Malaria Market Analysis by Regions

4.1 Global Drugs for Malaria Sales, Revenue and Market Share by Regions

4.1.1 Global Drugs for Malaria Sales and Market Share by Regions (2013-2018)

4.1.2 Global Drugs for Malaria Revenue and Market Share by Regions (2013-2018)

4.2 North America Drugs for Malaria Sales and Growth Rate (2013-2018)

4.3 Europe Drugs for Malaria Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Drugs for Malaria Sales and Growth Rate (2013-2018)

4.5 South America Drugs for Malaria Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Drugs for Malaria Sales and Growth Rate (2013-2018)

5 North America Drugs for Malaria by Countries

5.1 North America Drugs for Malaria Sales, Revenue and Market Share by Countries

5.1.1 North America Drugs for Malaria Sales and Market Share by Countries (2013-2018)

5.1.2 North America Drugs for Malaria Revenue and Market Share by Countries (2013-2018)

5.2 United States Drugs for Malaria Sales and Growth Rate (2013-2018)

5.3 Canada Drugs for Malaria Sales and Growth Rate (2013-2018)

5.4 Mexico Drugs for Malaria Sales and Growth Rate (2013-2018)

6 Europe Drugs for Malaria by Countries

6.1 Europe Drugs for Malaria Sales, Revenue and Market Share by Countries

6.1.1 Europe Drugs for Malaria Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Drugs for Malaria Revenue and Market Share by Countries (2013-2018)

6.2 Germany Drugs for Malaria Sales and Growth Rate (2013-2018)

6.3 UK Drugs for Malaria Sales and Growth Rate (2013-2018)

6.4 France Drugs for Malaria Sales and Growth Rate (2013-2018)

6.5 Russia Drugs for Malaria Sales and Growth Rate (2013-2018)

6.6 Italy Drugs for Malaria Sales and Growth Rate (2013-2018)

7 Asia-Pacific Drugs for Malaria by Countries

7.1 Asia-Pacific Drugs for Malaria Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Drugs for Malaria Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Drugs for Malaria Revenue and Market Share by Countries (2013-2018)

7.2 China Drugs for Malaria Sales and Growth Rate (2013-2018)

7.3 Japan Drugs for Malaria Sales and Growth Rate (2013-2018)

7.4 Korea Drugs for Malaria Sales and Growth Rate (2013-2018)

7.5 India Drugs for Malaria Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Drugs for Malaria Sales and Growth Rate (2013-2018)

8 South America Drugs for Malaria by Countries

8.1 South America Drugs for Malaria Sales, Revenue and Market Share by Countries

8.1.1 South America Drugs for Malaria Sales and Market Share by Countries (2013-2018)

8.1.2 South America Drugs for Malaria Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Drugs for Malaria Sales and Growth Rate (2013-2018)

8.3 Argentina Drugs for Malaria Sales and Growth Rate (2013-2018)

8.4 Colombia Drugs for Malaria Sales and Growth Rate (2013-2018)

9 Middle East and Africa Drugs for Malaria by Countries

9.1 Middle East and Africa Drugs for Malaria Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Drugs for Malaria Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Drugs for Malaria Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Drugs for Malaria Sales and Growth Rate (2013-2018)

9.3 UAE Drugs for Malaria Sales and Growth Rate (2013-2018)

9.4 Egypt Drugs for Malaria Sales and Growth Rate (2013-2018)

9.5 Nigeria Drugs for Malaria Sales and Growth Rate (2013-2018)

9.6 South Africa Drugs for Malaria Sales and Growth Rate (2013-2018)

10 Global Drugs for Malaria Market Segment by Type

10.1 Global Drugs for Malaria Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Drugs for Malaria Sales and Market Share by Type (2013-2018)

10.1.2 Global Drugs for Malaria Revenue and Market Share by Type (2013-2018)

10.2 Aryl Aminoalcohol Compounds Sales Growth and Price

10.2.1 Global Aryl Aminoalcohol Compounds Sales Growth (2013-2018)

10.2.2 Global Aryl Aminoalcohol Compounds Price (2013-2018)

10.3 Antifolate Compounds Sales Growth and Price

10.3.1 Global Antifolate Compounds Sales Growth (2013-2018)

10.3.2 Global Antifolate Compounds Price (2013-2018)

10.4 Artemisinin Compounds Sales Growth and Price

10.4.1 Global Artemisinin Compounds Sales Growth (2013-2018)

10.4.2 Global Artemisinin Compounds Price (2013-2018)

11 Global Drugs for Malaria Market Segment by Application

11.1 Global Drugs for Malaria Sales Market Share by Application (2013-2018)

11.2 Prevention Sales Growth (2013-2018)

11.3 Treatment Sales Growth (2013-2018)

11.4 Other Sales Growth (2013-2018)

12 Drugs for Malaria Market Forecast (2018-2023)

12.1 Global Drugs for Malaria Sales, Revenue and Growth Rate (2018-2023)

12.2 Drugs for Malaria Market Forecast by Regions (2018-2023)

12.2.1 North America Drugs for Malaria Market Forecast (2018-2023)

12.2.2 Europe Drugs for Malaria Market Forecast (2018-2023)

12.2.3 Asia-Pacific Drugs for Malaria Market Forecast (2018-2023)

12.2.4 South America Drugs for Malaria Market Forecast (2018-2023)

12.2.5 Middle East and Africa Drugs for Malaria Market Forecast (2018-2023)

12.3 Drugs for Malaria Market Forecast by Type (2018-2023)

12.3.1 Global Drugs for Malaria Sales Forecast by Type (2018-2023)

12.3.2 Global Drugs for Malaria Market Share Forecast by Type (2018-2023)

12.4 Drugs for Malaria Market Forecast by Application (2018-2023)

12.4.1 Global Drugs for Malaria Sales Forecast by Application (2018-2023)

12.4.2 Global Drugs for Malaria Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source


List Of Table

List of Tables and Figures

Figure Drugs for Malaria Picture

Table Product Specifications of Drugs for Malaria

Figure Global Sales Market Share of Drugs for Malaria by Types in 2017

Table Drugs for Malaria Types for Major Manufacturers

Figure Aryl Aminoalcohol Compounds Picture

Figure Antifolate Compounds Picture

Figure Artemisinin Compounds Picture

Figure Drugs for Malaria Sales Market Share by Applications in 2017

Figure Prevention Picture

Figure Treatment Picture

Figure Other Picture

Figure United States Drugs for Malaria Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Drugs for Malaria Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Drugs for Malaria Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Drugs for Malaria Revenue (Value) and Growth Rate (2013-2023)

Figure France Drugs for Malaria Revenue (Value) and Growth Rate (2013-2023)

Figure UK Drugs for Malaria Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Drugs for Malaria Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Drugs for Malaria Revenue (Value) and Growth Rate (2013-2023)

Figure China Drugs for Malaria Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Drugs for Malaria Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Drugs for Malaria Revenue (Value) and Growth Rate (2013-2023)

Figure India Drugs for Malaria Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Drugs for Malaria Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Drugs for Malaria Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Drugs for Malaria Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Drugs for Malaria Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Drugs for Malaria Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Drugs for Malaria Revenue (Value) and Growth Rate (2013-2023)

Table Cipla Basic Information, Manufacturing Base and Competitors

Table Cipla Drugs for Malaria Type and Applications

Table Cipla Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Guilin Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table Guilin Pharmaceutical Drugs for Malaria Type and Applications

Table Guilin Pharmaceutical Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table IPCA Laboratories Basic Information, Manufacturing Base and Competitors

Table IPCA Laboratories Drugs for Malaria Type and Applications

Table IPCA Laboratories Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors

Table GlaxoSmithKline Drugs for Malaria Type and Applications

Table GlaxoSmithKline Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Mylan Labs Basic Information, Manufacturing Base and Competitors

Table Mylan Labs Drugs for Malaria Type and Applications

Table Mylan Labs Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Roche Basic Information, Manufacturing Base and Competitors

Table Roche Drugs for Malaria Type and Applications

Table Roche Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Novartis Basic Information, Manufacturing Base and Competitors

Table Novartis Drugs for Malaria Type and Applications

Table Novartis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Sanofi Aventis Basic Information, Manufacturing Base and Competitors

Table Sanofi Aventis Drugs for Malaria Type and Applications

Table Sanofi Aventis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Ajanta Pharma Basic Information, Manufacturing Base and Competitors

Table Ajanta Pharma Drugs for Malaria Type and Applications

Table Ajanta Pharma Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Drugs for Malaria Sales by Manufacturer (2016-2017)

Figure Global Drugs for Malaria Sales Market Share by Manufacturer in 2016

Figure Global Drugs for Malaria Sales Market Share by Manufacturer in 2017

Table Global Drugs for Malaria Revenue by Manufacturer (2016-2017)

Figure Global Drugs for Malaria Revenue Market Share by Manufacturer in 2016

Figure Global Drugs for Malaria Revenue Market Share by Manufacturer in 2017

Figure Top 3 Drugs for Malaria Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Drugs for Malaria Manufacturer (Revenue) Market Share in 2017

Figure Global Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure Global Drugs for Malaria Revenue and Growth Rate (2013-2018)

Table Global Drugs for Malaria Sales by Regions (2013-2018)

Table Global Drugs for Malaria Sales Market Share by Regions (2013-2018)

Table Global Drugs for Malaria Revenue by Regions (2013-2018)

Figure Global Drugs for Malaria Revenue Market Share by Regions in 2013

Figure Global Drugs for Malaria Revenue Market Share by Regions in 2017

Figure North America Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure Europe Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure South America Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure North America Drugs for Malaria Revenue and Growth Rate (2013-2018)

Table North America Drugs for Malaria Sales by Countries (2013-2018)

Table North America Drugs for Malaria Sales Market Share by Countries (2013-2018)

Figure North America Drugs for Malaria Sales Market Share by Countries in 2013

Figure North America Drugs for Malaria Sales Market Share by Countries in 2017

Table North America Drugs for Malaria Revenue by Countries (2013-2018)

Table North America Drugs for Malaria Revenue Market Share by Countries (2013-2018)

Figure North America Drugs for Malaria Revenue Market Share by Countries in 2013

Figure North America Drugs for Malaria Revenue Market Share by Countries in 2017

Figure United States Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure Canada Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure Mexico Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure Europe Drugs for Malaria Revenue and Growth Rate (2013-2018)

Table Europe Drugs for Malaria Sales by Countries (2013-2018)

Table Europe Drugs for Malaria Sales Market Share by Countries (2013-2018)

Table Europe Drugs for Malaria Revenue by Countries (2013-2018)

Figure Europe Drugs for Malaria Revenue Market Share by Countries in 2016

Figure Europe Drugs for Malaria Revenue Market Share by Countries in 2017

Figure Germany Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure UK Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure France Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure Russia Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure Italy Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Drugs for Malaria Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Drugs for Malaria Sales by Countries (2013-2018)

Table Asia-Pacific Drugs for Malaria Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Drugs for Malaria Sales Market Share by Countries 2017

Table Asia-Pacific Drugs for Malaria Revenue by Countries (2013-2018)

Figure Asia-Pacific Drugs for Malaria Revenue Market Share by Countries 2017

Figure China Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure Japan Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure Korea Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure India Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure Southeast Asia Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure South America Drugs for Malaria Revenue and Growth Rate (2013-2018)

Table South America Drugs for Malaria Sales by Countries (2013-2018)

Table South America Drugs for Malaria Sales Market Share by Countries (2013-2018)

Figure South America Drugs for Malaria Sales Market Share by Countries in 2017

Table South America Drugs for Malaria Revenue by Countries (2013-2018)

Table South America Drugs for Malaria Revenue Market Share by Countries (2013-2018)

Figure South America Drugs for Malaria Revenue Market Share by Countries in 2017

Figure Brazil Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure Argentina Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure Colombia Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Drugs for Malaria Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Drugs for Malaria Sales by Countries (2013-2018)

Table Middle East and Africa Drugs for Malaria Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Drugs for Malaria Sales Market Share by Countries in 2017

Table Middle East and Africa Drugs for Malaria Revenue by Countries (2013-2018)

Table Middle East and Africa Drugs for Malaria Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Drugs for Malaria Revenue Market Share by Countries in 2013

Figure Middle East and Africa Drugs for Malaria Revenue Market Share by Countries in 2017

Figure Saudi Arabia Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure UAE Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure Egypt Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure Nigeria Drugs for Malaria Sales and Growth Rate (2013-2018)

Figure South Africa Drugs for Malaria Sales and Growth Rate (2013-2018)

Table Global Drugs for Malaria Sales by Type (2013-2018)

Table Global Drugs for Malaria Sales Share by Type (2013-2018)

Table Global Drugs for Malaria Revenue by Type (2013-2018)

Table Global Drugs for Malaria Revenue Share by Type (2013-2018)

Figure Global Aryl Aminoalcohol Compounds Sales Growth (2013-2018)

Figure Global Aryl Aminoalcohol Compounds Price (2013-2018)

Figure Global Antifolate Compounds Sales Growth (2013-2018)

Figure Global Antifolate Compounds Price (2013-2018)

Figure Global Artemisinin Compounds Sales Growth (2013-2018)

Figure Global Artemisinin Compounds Price (2013-2018)

Table Global Drugs for Malaria Sales by Application (2013-2018)

Table Global Drugs for Malaria Sales Share by Application (2013-2018)

Figure Global Treatment Sales Growth (2013-2018)

Figure Global Other Sales Growth (2013-2018)

Figure Global Drugs for Malaria Sales, Revenue and Growth Rate (2018-2023)

Table Global Drugs for Malaria Sales Forecast by Regions (2018-2023)

Table Global Drugs for Malaria Market Share Forecast by Regions (2018-2023)

Figure North America Sales Drugs for Malaria Market Forecast (2018-2023)

Figure Europe Sales Drugs for Malaria Market Forecast (2018-2023)

Figure Asia-Pacific Sales Drugs for Malaria Market Forecast (2018-2023)

Figure South America Sales Drugs for Malaria Market Forecast (2018-2023)

Figure Middle East and Africa Sales Drugs for Malaria Market Forecast (2018-2023)

Table Global Drugs for Malaria Sales Forecast by Type (2018-2023)

Table Global Drugs for Malaria Market Share Forecast by Type (2018-2023)

Table Global Drugs for Malaria Sales Forecast by Application (2018-2023)

Table Global Drugs for Malaria Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Companies

Cipla

Guilin Pharmaceutical

IPCA Laboratories

GlaxoSmithKline

Mylan Labs

Roche

Novartis

Sanofi Aventis

Ajanta Pharma

chat_bubbleLet's Chat